Long-term ecological impacts of antibiotic administration on the human intestinal microbiota.

PubWeight™: 3.92‹?› | Rank: Top 1%

🔗 View Article (PMID 18043614)

Published in ISME J on May 01, 2007

Authors

Cecilia Jernberg1, Sonja Löfmark, Charlotta Edlund, Janet K Jansson

Author Affiliations

1: Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden.

Articles citing this

(truncated to the top 100)

The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol (2008) 16.57

Diversity, stability and resilience of the human gut microbiota. Nature (2012) 9.09

Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation. Infect Immun (2009) 7.48

The impact of the gut microbiota on human health: an integrative view. Cell (2012) 6.01

Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc Natl Acad Sci U S A (2009) 5.86

The application of ecological theory toward an understanding of the human microbiome. Science (2012) 4.69

Genomic variation landscape of the human gut microbiome. Nature (2012) 4.38

Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice. PLoS Pathog (2012) 3.81

Specificity of polysaccharide use in intestinal bacteroides species determines diet-induced microbiota alterations. Cell (2010) 3.70

Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome. PLoS One (2010) 3.45

Antibiotic treatment of clostridium difficile carrier mice triggers a supershedder state, spore-mediated transmission, and severe disease in immunocompromised hosts. Infect Immun (2009) 3.36

Microbiota-mediated colonization resistance against intestinal pathogens. Nat Rev Immunol (2013) 2.89

Profound alterations of intestinal microbiota following a single dose of clindamycin results in sustained susceptibility to Clostridium difficile-induced colitis. Infect Immun (2011) 2.87

Use of Antibiotics and Risk of Type 2 Diabetes: A Population-Based Case-Control Study. J Clin Endocrinol Metab (2015) 2.82

Familial transmission rather than defective innate immunity shapes the distinct intestinal microbiota of TLR-deficient mice. J Exp Med (2012) 2.62

Role of the commensal microbiota in normal and pathogenic host immune responses. Cell Host Microbe (2011) 2.46

From structure to function: the ecology of host-associated microbial communities. Microbiol Mol Biol Rev (2010) 2.42

Reshaping the gut microbiome with bacterial transplantation and antibiotic intake. Genome Res (2010) 2.21

Ecological modeling from time-series inference: insight into dynamics and stability of intestinal microbiota. PLoS Comput Biol (2013) 2.16

Gut microbiota disturbance during antibiotic therapy: a multi-omic approach. Gut (2012) 2.10

Human gut microbiome adopts an alternative state following small bowel transplantation. Proc Natl Acad Sci U S A (2009) 2.08

Intestinal microbiome is related to lifetime antibiotic use in Finnish pre-school children. Nat Commun (2016) 2.03

Gut microbiota, probiotics, and vitamin D: interrelated exposures influencing allergy, asthma, and obesity? J Allergy Clin Immunol (2011) 2.01

Intestinal microbiota in healthy adults: temporal analysis reveals individual and common core and relation to intestinal symptoms. PLoS One (2011) 1.88

Intestinal colonization resistance. Immunology (2013) 1.85

Robustness of gut microbiota of healthy adults in response to probiotic intervention revealed by high-throughput pyrosequencing. DNA Res (2013) 1.78

Intestinal microbiota in human health and disease: the impact of probiotics. Genes Nutr (2011) 1.63

Uncovering effects of antibiotics on the host and microbiota using transkingdom gene networks. Gut (2015) 1.63

Antibiotic Exposure and Juvenile Idiopathic Arthritis: A Case-Control Study. Pediatrics (2015) 1.56

Comparative analysis of Korean human gut microbiota by barcoded pyrosequencing. PLoS One (2011) 1.49

'Blooming' in the gut: how dysbiosis might contribute to pathogen evolution. Nat Rev Microbiol (2013) 1.45

The altered gut microbiota in adults with cystic fibrosis. BMC Microbiol (2017) 1.40

Antibiotics and the gut microbiota. J Clin Invest (2014) 1.39

Intestinal microbial ecology and environmental factors affecting necrotizing enterocolitis. PLoS One (2013) 1.36

Impact of the gut microbiota on the development of obesity and type 2 diabetes mellitus. Front Microbiol (2014) 1.35

Antibiotics, microbiota, and immune defense. Trends Immunol (2012) 1.33

Our microbial selves: what ecology can teach us. EMBO Rep (2011) 1.31

The human microbiome: ecosystem resilience and health. Nutr Rev (2012) 1.30

Robustness of the bacterial community in the cabbage white butterfly larval midgut. Microb Ecol (2010) 1.29

Comparison of the cecal microbiota of domestic and wild turkeys. Microb Ecol (2008) 1.29

Pyrosequencing analysis of the human microbiota of healthy Chinese undergraduates. BMC Genomics (2013) 1.26

Composition of the early intestinal microbiota: knowledge, knowledge gaps and the use of high-throughput sequencing to address these gaps. Gut Microbes (2012) 1.23

Perinatal programming of asthma: the role of gut microbiota. Clin Dev Immunol (2011) 1.21

Upper respiratory tract microbial communities, acute otitis media pathogens, and antibiotic use in healthy and sick children. Appl Environ Microbiol (2012) 1.17

Gut microbiota, immunity, and disease: a complex relationship. Front Microbiol (2011) 1.17

Succession in the gut microbiome following antibiotic and antibody therapies for Clostridium difficile. PLoS One (2012) 1.16

Defining the human microbiome. Nutr Rev (2012) 1.15

Role of the normal gut microbiota. World J Gastroenterol (2015) 1.12

Short-term effect of antibiotics on human gut microbiota. PLoS One (2014) 1.12

The human gut resistome. Philos Trans R Soc Lond B Biol Sci (2015) 1.10

The effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulation. Genome Med (2016) 1.08

Seasonal variation in human gut microbiome composition. PLoS One (2014) 1.06

The microbiome of the middle meatus in healthy adults. PLoS One (2013) 1.06

Food and human gut as reservoirs of transferable antibiotic resistance encoding genes. Front Microbiol (2013) 1.04

Antibiotics and the Human Gut Microbiome: Dysbioses and Accumulation of Resistances. Front Microbiol (2016) 1.03

Gut microbiota as potential orchestrators of irritable bowel syndrome. Gut Liver (2015) 1.03

Cross-sectional and longitudinal comparisons of the predominant fecal microbiota compositions of a group of pediatric patients with cystic fibrosis and their healthy siblings. Appl Environ Microbiol (2011) 1.01

Functional and phylogenetic assembly of microbial communities in the human microbiome. Trends Microbiol (2014) 1.01

Modeling the impact of antibiotic exposure on human microbiota. Sci Rep (2014) 1.01

Temporal and technical variability of human gut metagenomes. Genome Biol (2015) 1.00

The intestinal microbiota dysbiosis and Clostridium difficile infection: is there a relationship with inflammatory bowel disease? Therap Adv Gastroenterol (2013) 1.00

Wolbachia: Can we save lives with a great pandemic? Trends Parasitol (2013) 0.97

The skin microbiome: current perspectives and future challenges. J Am Acad Dermatol (2013) 0.97

Microbiome: That healthy gut feeling. Nature (2011) 0.97

The altered gut microbiome and necrotizing enterocolitis. Clin Perinatol (2013) 0.97

The gut microbiota of Colombians differs from that of Americans, Europeans and Asians. BMC Microbiol (2014) 0.95

Pyrosequencing analysis of the salivary microbiota of healthy Chinese children and adults. Microb Ecol (2012) 0.95

Impact of colonoscopy bowel preparation on intestinal microbiota. PLoS One (2013) 0.95

Antibiotic-Induced Changes in the Intestinal Microbiota and Disease. Trends Mol Med (2016) 0.94

Role of microbiota and innate immunity in recurrent Clostridium difficile infection. J Immunol Res (2014) 0.93

Pharmacomicrobiomics: the impact of human microbiome variations on systems pharmacology and personalized therapeutics. OMICS (2014) 0.92

Characterization of the gut-associated microbiome in inflammatory pouch complications following ileal pouch-anal anastomosis. PLoS One (2013) 0.92

Effectiveness of fecal-derived microbiota transfer using orally administered capsules for recurrent Clostridium difficile infection. BMC Infect Dis (2015) 0.92

Horizontal gene transfer in the human gastrointestinal tract: potential spread of antibiotic resistance genes. Infect Drug Resist (2014) 0.91

Microbial regulation of allergic responses to food. Semin Immunopathol (2012) 0.90

An environment-sensitive synthetic microbial ecosystem. PLoS One (2010) 0.89

Emerging Insights into Antibiotic-Associated Diarrhea and Clostridium difficile Infection through the Lens of Microbial Ecology. Interdiscip Perspect Infect Dis (2008) 0.89

A specific prebiotic mixture added to starting infant formula has long-lasting bifidogenic effects. J Nutr (2011) 0.88

Antibiotic use and childhood body mass index trajectory. Int J Obes (Lond) (2015) 0.87

Modulation of gut microbiota in the management of metabolic disorders: the prospects and challenges. Int J Mol Sci (2014) 0.87

Effects of β-lactam antibiotics and fluoroquinolones on human gut microbiota in relation to Clostridium difficile associated diarrhea. PLoS One (2014) 0.86

Modulation of post-antibiotic bacterial community reassembly and host response by Candida albicans. Sci Rep (2013) 0.86

Effect of Antibiotics on Gut Microbiota, Gut Hormones and Glucose Metabolism. PLoS One (2015) 0.85

Antibiotics and the developing infant gut microbiota and resistome. Curr Opin Microbiol (2015) 0.85

The role of the immune system in regulating the microbiota. Gut Microbes (2010) 0.85

The yin and yang of bacterial resilience in the human gut microbiota. J Mol Biol (2014) 0.84

Integrons in the intestinal microbiota as reservoirs for transmission of antibiotic resistance genes. Pathogens (2014) 0.84

Environment, dysbiosis, immunity and sex-specific susceptibility: a translational hypothesis for regressive autism pathogenesis. Nutr Neurosci (2014) 0.84

The chemical interactome space between the human host and the genetically defined gut metabotypes. ISME J (2012) 0.84

Development of the infant intestinal microbiome: A bird's eye view of a complex process. Birth Defects Res C Embryo Today (2015) 0.84

Shaping the (auto)immune response in the gut: the role of intestinal immune regulation in the prevention of type 1 diabetes. Am J Clin Exp Immunol (2013) 0.84

DNA microarray analysis reveals that antibiotic resistance-gene diversity in human gut microbiota is age related. Sci Rep (2014) 0.83

Antibiotic resistance is widespread in urban aquatic environments of Rio de Janeiro, Brazil. Microb Ecol (2014) 0.83

Humanized microbiota mice as a model of recurrent Clostridium difficile disease. Microbiome (2015) 0.82

Colonization Resistance of the Gut Microbiota against Clostridium difficile. Antibiotics (Basel) (2015) 0.82

Gut microbiota-host interactions and juvenile idiopathic arthritis. Pediatr Rheumatol Online J (2016) 0.82

Antibiotic Exposure, Infection, and the Development of Pediatric Psoriasis: A Nested Case-Control Study. JAMA Dermatol (2016) 0.81

Elucidating the role of the host genome in shaping microbiome composition. Gut Microbes (2016) 0.81

Immune Responses to Broad-Spectrum Antibiotic Treatment and Fecal Microbiota Transplantation in Mice. Front Immunol (2017) 0.81

Gut microbes and adverse food reactions: Focus on gluten related disorders. Gut Microbes (2014) 0.81

Articles by these authors

DNA Probe Method for the Detection of Specific Microorganisms in the Soil Bacterial Community. Appl Environ Microbiol (1988) 13.80

Diversity, stability and resilience of the human gut microbiota. Nature (2012) 9.09

Deep-sea oil plume enriches indigenous oil-degrading bacteria. Science (2010) 6.73

A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology (2010) 5.29

Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea. J Clin Gastroenterol (2010) 4.52

Metagenomic analysis of a permafrost microbial community reveals a rapid response to thaw. Nature (2011) 3.80

Long-term impacts of antibiotic exposure on the human intestinal microbiota. Microbiology (2010) 3.68

Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome. PLoS One (2010) 3.45

Shotgun metaproteomics of the human distal gut microbiota. ISME J (2008) 3.43

Molecular analysis of the gut microbiota of identical twins with Crohn's disease. ISME J (2008) 2.96

Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohn's disease. Inflamm Bowel Dis (2009) 2.85

Tackling soil diversity with the assembly of large, complex metagenomes. Proc Natl Acad Sci U S A (2014) 2.65

The Earth Microbiome project: successes and aspirations. BMC Biol (2014) 2.58

Metronidazole is still the drug of choice for treatment of anaerobic infections. Clin Infect Dis (2010) 2.45

Metagenome, metatranscriptome and single-cell sequencing reveal microbial response to Deepwater Horizon oil spill. ISME J (2012) 2.45

Meta-analyses of studies of the human microbiota. Genome Res (2013) 2.35

Microbial gene functions enriched in the Deepwater Horizon deep-sea oil plume. ISME J (2011) 2.10

Rational use of aminoglycosides--review and recommendations by the Swedish Reference Group for Antibiotics (SRGA). Scand J Infect Dis (2012) 2.06

Interactions between arbuscular mycorrhizal fungi and bacteria and their potential for stimulating plant growth. Environ Microbiol (2006) 1.88

Integrated metagenomics/metaproteomics reveals human host-microbiota signatures of Crohn's disease. PLoS One (2012) 1.84

Reduction of the fitness burden of quinolone resistance in Pseudomonas aeruginosa. J Antimicrob Chemother (2004) 1.75

Molecular characterization of the stomach microbiota in patients with gastric cancer and in controls. J Med Microbiol (2009) 1.64

Soft inertial microfluidics for high throughput separation of bacteria from human blood cells. Lab Chip (2009) 1.63

Deep-sea bacteria enriched by oil and dispersant from the Deepwater Horizon spill. Environ Microbiol (2012) 1.58

Clindamycin-induced enrichment and long-term persistence of resistant Bacteroides spp. and resistance genes. J Antimicrob Chemother (2006) 1.40

Impact of phenolic substrate and growth temperature on the Arthrobacter chlorophenolicus proteome. J Proteome Res (2009) 1.31

Molecular fingerprinting of the fecal microbiota of children raised according to different lifestyles. Appl Environ Microbiol (2007) 1.23

Monitoring of antibiotic-induced alterations in the human intestinal microflora and detection of probiotic strains by use of terminal restriction fragment length polymorphism. Appl Environ Microbiol (2005) 1.21

Use of bromodeoxyuridine immunocapture to identify active bacteria associated with arbuscular mycorrhizal hyphae. Appl Environ Microbiol (2003) 1.20

Strategies for metagenomic-guided whole-community proteomics of complex microbial environments. PLoS One (2011) 1.09

Novel 4-chlorophenol degradation gene cluster and degradation route via hydroxyquinol in Arthrobacter chlorophenolicus A6. Appl Environ Microbiol (2005) 1.08

Chitinase genes revealed and compared in bacterial isolates, DNA extracts and a metagenomic library from a phytopathogen-suppressive soil. FEMS Microbiol Ecol (2009) 1.08

Inducible metronidazole resistance and nim genes in clinical Bacteroides fragilis group isolates. Antimicrob Agents Chemother (2005) 1.06

Omics for understanding microbial functional dynamics. Environ Microbiol (2011) 1.04

In vivo study of trichoderma-pathogen-plant interactions, using constitutive and inducible green fluorescent protein reporter systems. Appl Environ Microbiol (2004) 1.03

Combined bromodeoxyuridine immunocapture and terminal-restriction fragment length polymorphism analysis highlights differences in the active soil bacterial metagenome due to Glomus mosseae inoculation or plant species. Environ Microbiol (2005) 1.03

Attachment of different soil bacteria to arbuscular mycorrhizal fungal extraradical hyphae is determined by hyphal vitality and fungal species. FEMS Microbiol Lett (2006) 1.02

Active bacterial community structure along vertical redox gradients in Baltic Sea sediment. Environ Microbiol (2008) 1.02

Degradation of mixtures of phenolic compounds by Arthrobacter chlorophenolicus A6. Biodegradation (2007) 1.01

Microbial community structure in polluted Baltic Sea sediments. Environ Microbiol (2006) 0.99

Bloodstream isolates of Enterococcus faecium enriched with the enterococcal surface protein gene, esp, show increased adhesion to eukaryotic cells. J Clin Microbiol (2003) 0.98

Restored fitness leads to long-term persistence of resistant Bacteroides strains in the human intestine. Anaerobe (2008) 0.98

Adaptation of the psychrotroph Arthrobacter chlorophenolicus A6 to growth temperature and the presence of phenols by changes in the anteiso/iso ratio of branched fatty acids. FEMS Microbiol Lett (2007) 0.97

Advances in preservation methods: keeping biosensor microorganisms alive and active. Curr Opin Biotechnol (2005) 0.96

Multiresistant coagulase-negative staphylococci disseminate frequently between intubated patients in a multidisciplinary intensive care unit. Crit Care (2003) 0.96

Genetic basis of resistance in Propionibacterium acnes strains isolated from diverse types of infection in different European countries. Anaerobe (2005) 0.96

Invasive candidiasis in long-term patients at a multidisciplinary intensive care unit: Candida colonization index, risk factors, treatment and outcome. Scand J Infect Dis (2008) 0.95

Microbes in thawing permafrost: the unknown variable in the climate change equation. ISME J (2011) 0.94

New findings in beta-lactam and metronidazole resistant Bacteroides fragilis group. Int J Antimicrob Agents (2002) 0.90

Community structure of actively growing bacterial populations in plant pathogen suppressive soil. Microb Ecol (2006) 0.89

Impact of temperature on the physiological status of a potential bioremediation inoculant, Arthrobacter chlorophenolicus A6. Appl Environ Microbiol (2004) 0.89

Frequent transmission of enterococcal strains between mechanically ventilated patients treated at an intensive care unit. J Clin Microbiol (2002) 0.88

Neisseria gonorrhoeae infection causes DNA damage and affects the expression of p21, p27 and p53 in non-tumor epithelial cells. J Cell Sci (2012) 0.87

Gastrointestinal transit survival of an Enterococcus faecium probiotic strain administered with or without vancomycin. Int J Food Microbiol (2002) 0.87

Impact of 4-chlorophenol contamination and/or inoculation with the 4-chlorophenol-degrading strain, Arthrobacter chlorophenolicus A6L, on soil bacterial community structure. FEMS Microbiol Ecol (2002) 0.86

The global need for effective antibiotics-a summary of plenary presentations. Drug Resist Updat (2011) 0.86

Microbiology: The life beneath our feet. Nature (2013) 0.86

Changes in active bacterial communities before and after dredging of highly polluted Baltic Sea sediments. Appl Environ Microbiol (2006) 0.84

'Omics' of the mammalian gut--new insights into function. Curr Opin Biotechnol (2012) 0.83

Long-term antimicrobial resistance in Escherichia coli from human intestinal microbiota after administration of clindamycin. Scand J Infect Dis (2007) 0.83

Use of a novel nonantibiotic triple marker gene cassette to monitor high survival of Pseudomonas fluorescens SBW25 on winter wheat in the field. FEMS Microbiol Ecol (2007) 0.83

Amino acid treatment enhances protein recovery from sediment and soils for metaproteomic studies. Proteomics (2013) 0.82

Monitoring physiological status of GFP-tagged Pseudomonas fluorescens SBW25 under different nutrient conditions and in soil by flow cytometry. FEMS Microbiol Ecol (2004) 0.81

ICU stay promotes enrichment and dissemination of multiresistant coagulase-negative staphylococcal strains. Scand J Infect Dis (2006) 0.81

Rapid lab-on-a-chip profiling of human gut bacteria. J Microbiol Methods (2007) 0.81

Lactobacillus decelerates cervical epithelial cell cycle progression. PLoS One (2013) 0.79

Use of bromodeoxyuridine immunocapture to identify psychrotolerant phenanthrene-degrading bacteria in phenanthrene-enriched polluted Baltic Sea sediments. FEMS Microbiol Ecol (2008) 0.79

Antibiotic properties of novel synthetic temporin A analogs and a cecropin A-temporin A hybrid peptide. Protein Pept Lett (2002) 0.78

Selection of cefoxitin-resistant bacteroides thetaiotaomicron mutants and mechanisms involved in beta-lactam resistance. Clin Infect Dis (2002) 0.78

Limited Dissemination of Extended-Spectrum β-Lactamase- and Plasmid-Encoded AmpC-Producing Escherichia coli from Food and Farm Animals, Sweden. Emerg Infect Dis (2016) 0.77

Specific interactions between arbuscular mycorrhizal fungi and plant growth-promoting bacteria: as revealed by different combinations. FEMS Microbiol Lett (2008) 0.76

Prolonged impact of a one-week course of clindamycin on Enterococcus spp. in human normal microbiota. Scand J Infect Dis (2009) 0.76

[New recommendations for antibiotics in dental care also relevant for physicians]. Lakartidningen (2014) 0.75

Lakartidningen (2017) 0.75